Clinical Trial Update: Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating safety and efficacy of anlotinib in combination with irinotecan in pretreated advanced colorectal cancer (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Colo-rectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN